XML 16 R2.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
CURRENT ASSETS:    
Cash and cash equivalents $ 275,834 $ 334,427
Marketable securities 6,255 7,439
Research and development tax credits receivable 2,598 2,580
Income tax receivable 799 0
Other receivables 1,010 654
Prepaid expenses 3,242 6,314
Total current assets 289,738 351,414
Property and equipment, net 5,124 5,604
Operating lease right-of-use assets 6,456 7,491
Other assets 497 586
Deferred tax assets 6,229 3,620
TOTAL ASSETS 308,044 368,715
CURRENT LIABILITIES:    
Accounts payable 4,991 2,302
Accrued expenses and other current liabilities 20,459 18,622
Operating lease liability, current portion 2,135 1,721
Deferred revenue, current portion 11,855 11,921
Income tax payable 0 523
Total current liabilities 39,440 35,089
Operating lease liability, net of current portion 4,495 5,592
Deferred revenue, net of current portion 38,592 39,613
TOTAL LIABILITIES 82,527 80,294
SHAREHOLDERS’ EQUITY    
Preferred shares, no par value per share; unlimited shares authorized as of September 30, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding as of September 30, 2021, and December 31, 2020, respectively 0 0
Common shares, no par value per share; unlimited shares authorized as of September 30, 2021 and December 31, 2020; 37,133,938 and 36,902,924 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 481,380 480,699
Additional paid-in capital 27,253 17,988
Accumulated deficit (283,116) (210,266)
Total shareholders’ equity 225,517 288,421
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 308,044 $ 368,715